Back to BT Blue Trust, Inc.
VKTX
Showing 8 of 13 quarters
Position history for BTBlue Trust, Inc.'s holdings in Viking Therapeutics, Inc.
Yes. Blue Trust holds 396 shares of VKTX (Viking Therapeutics), worth $12,910, as of its Q3 2026 13F filing. It reduced the position by 86 shares (-17.8%) from Q2 2026. Blue Trust has held VKTX since Q3 2024, across 9 quarterly 13F filings.
Current Value
$12,910
Current Shares
396
Total Value Change
-$62,942
Total Shares Change
-1,489
Quarter-by-Quarter History